Lifestyle intervention and impaired glucose tolerance in the Da Qing study - Authors' reply

Correction: Cardiac arrest due to acquired long QT syndrome during gynecologic laparoscopy: a case report.

Frontiers in medicine·2026

Impact of Metformin Plus Lifestyle Intervention Compared With Lifestyle Intervention Alone on Prediabetes Remission in Participants With Impaired Glucose Regulation: The China DPP Study.

Diabetes, obesity & metabolism·2026

Identification and Functional Analysis of Candidate Effectors in the Sorghum Aphid, Melanaphis sorghi.

Insects·2026

Restoring autophagy-apoptosis balance in diabetic cardiomyopathy via a biomimetic, ROS-responsive nanocarrier associated with Mst1 pathway modulation.

Journal of nanobiotechnology·2026

Early Weight Loss in Impaired Glucose Tolerance Is Associated With Reduced Long-term Mortality and Cardiovascular Risk: The Da Qing Diabetes Prevention Outcome Study.

Diabetes care·2026

Development and Validation of an Interpretable Machine Learning-Based Clinical Prediction Model for Short-Term Mortality in Intracerebral Hemorrhage With Thrombocytopenia: A Multicenter Study.

CNS neuroscience & therapeutics·2026

Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study.

The lancet. Diabetes & endocrinology·2026

From adiposity to multisystem morbidity: the case for weight loss as disease modification.

The lancet. Diabetes & endocrinology·2026

Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.

The lancet. Diabetes & endocrinology·2026

Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial.

The lancet. Diabetes & endocrinology·2026

Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.

The lancet. Diabetes & endocrinology·2026

Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.

The lancet. Diabetes & endocrinology·2026

Treatment strategies for functional hypogonadism in obese men: a systematic review and network meta-analysis.

The journal of sexual medicine·2026

A randomized controlled trial of a multimodality digital health intervention to aid the delivery of the modified ketogenic diet therapy for epilepsy: The Keto eCoach trial protocol.

Epilepsia open·2026

Efficacy of an Interactive Life Simulation Gaming App on Improving HIV Testing Uptake Among Adolescents and Young Adults at Risk for HIV: Results of a Randomized Controlled Trial.

JMIR serious games·2026

Related Experiment Videos

Lifestyle intervention and impaired glucose tolerance in the Da Qing study - Authors' reply

Related Concept Videos

Correction: Cardiac arrest due to acquired long QT syndrome during gynecologic laparoscopy: a case report.

Impact of Metformin Plus Lifestyle Intervention Compared With Lifestyle Intervention Alone on Prediabetes Remission in Participants With Impaired Glucose Regulation: The China DPP Study.

Identification and Functional Analysis of Candidate Effectors in the Sorghum Aphid, Melanaphis sorghi.

Restoring autophagy-apoptosis balance in diabetic cardiomyopathy via a biomimetic, ROS-responsive nanocarrier associated with Mst1 pathway modulation.

Early Weight Loss in Impaired Glucose Tolerance Is Associated With Reduced Long-term Mortality and Cardiovascular Risk: The Da Qing Diabetes Prevention Outcome Study.

Development and Validation of an Interpretable Machine Learning-Based Clinical Prediction Model for Short-Term Mortality in Intracerebral Hemorrhage With Thrombocytopenia: A Multicenter Study.

Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case-control study.

From adiposity to multisystem morbidity: the case for weight loss as disease modification.

Efficacy and safety of mazdutide in adults with obesity or overweight: a US-based, multicentre, phase 2, randomised, placebo-controlled clinical trial.

Long-term safety of oral orforglipron in Japanese participants with type 2 diabetes (ACHIEVE-J): a multicentre, randomised, open-label, parallel-group phase 3 trial.

Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, multicentre, treat-to-target, randomised, phase 3b trial.

Efficacy and safety of once-weekly semaglutide 2·4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.

Treatment strategies for functional hypogonadism in obese men: a systematic review and network meta-analysis.

A randomized controlled trial of a multimodality digital health intervention to aid the delivery of the modified ketogenic diet therapy for epilepsy: The Keto eCoach trial protocol.

Efficacy of an Interactive Life Simulation Gaming App on Improving HIV Testing Uptake Among Adolescents and Young Adults at Risk for HIV: Results of a Randomized Controlled Trial.

Related Experiment Videos

Lifestyle intervention and impaired glucose tolerance in the Da Qing study - Authors' reply

Related Concept Videos

Related Articles